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Abstract 
Degree Project, Programme in Medicine, Colorectal cancer in a Sri Lankan teaching hospital, 
Sofia Lindskogen, 2020, Department of Surgery, University of Gothenburg, Sweden. 
Background: The economy in Sri Lanka has improved the last decades. Along with the 
prosperity of the country comes an increase in non-communicable diseases, such as colorectal 
cancer. Previous studies in South Asia suggests that the colorectal cancer differs in character 
from in the West regarding tumour location, age, tumour stage and survival.  
Aim: To compare patterns and long term outcome of colorectal cancer in a Sri Lankan 
hospital and two Swedish National Colorectal cancer Registers.  
Method: A retrospective medical record study including 185 patients diagnosed with 
colorectal cancer at Colombo South Teaching Hospital, Sri Lanka. Data was collected from 
the 5th of February to the 16th of Mars 2020. Swedish data was obtained from two National 
Colorectal Cancer Registers. 
Results: 18% of the patients were younger than 50 years old, a more than three times higher 
proportion than in Sweden (5%). The mean age differed with almost 10 years, 62 in Sri Lanka 
and 71 in Sweden. Tumour location was also different. 60% rectal and 40% colon tumours in 
Sri Lanka versus 29% rectal and 71% colon tumours in Sweden. 9 of the 68 patients that were 
followed for 5 years died and 13 encountered recurrence. The absolute 5-year survival was 
88% and the risk for recurrence within 5 years was 24%. Corresponding Swedish numbers for 
absolute 5-year survival was 82%, which resulted in no significant difference between the two 
countries. 
Conclusion: Differences could be detected between Sri Lanka and Sweden regarding age and 
tumour location, since Sri Lanka has a younger group of CRC patients with primarily rectal 
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tumours. No statistically significant difference in absolute 5-year survival was found between 
the studied groups.  
Key words: Colorectal cancer, Sri Lanka, Sweden, disease pattern, long term outcome 
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Introduction  
About Sri Lanka  
The Democratic Socialistic Republic of Sri Lanka is an island nation in South Asia and has a 
total population of 21.2 million people [1]. In spite of being hit by the tsunami in 2004 and 
suffering from a three-decade-long destructive civil war, which ended first in 2009, the 
country has been on steady road towards development. For the last decades the economy has 
improved. Gross National income (GNI) per capita (2011 PPP $) has increased more than 
eightfold from 1990 to 2018 [2]. Also, many health parameters have encountered substantial 
improvement. Life expectancy at birth has reached 75.5 years [1]. The under-five mortality 
rate per 1000 live births has reduced from 22 (1990) to 7.5 (2018) [3]. The maternal mortality 
ratio (MMR) per 100 000 live births has gone from 92 (1990) to 33.7 (2015) [4]. In contrast to 
India with MMR 145, Pakistan 140 and South Asia in total 163 it becomes clear how far Sri 
Lanka has reached when it comes to development [5]. 
 
Another indication of the progress in the country is the Human Development Index, HDI.  
HDI is an index made by the UN Development Programme. It summarizes the key aspects of 
the human development in each country: life expectancy at birth, access to knowledge and 
standard of living. A new index is set every year, making it possible to follow trends [6]. HDI 
in Sri Lanka was 0.770 in the year of 2018, compared to 0.625 in 1990. That places the 
country above the average level, rank 76 [1]. Corresponding figure for Sweden in 2018 was 
0.937 [7]. 
 
The robust health care system in the country is partly liable for the good results in health 
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indicators. Free health care for all citizens is provided by the government [8]. Hospitals and 
other kinds of health service facilities are located in the whole country, though more 
peripheral areas still remain without physical availability. Public health care provides 95% of 
inpatient and 45% of outpatient care. The remaining part is taken care of by the private sector 
[4]. Private care started in the 1980’s and though the engagement now is limited, it has a gap 
to fill and opportunities to grow. The long waiting time for specialist care indicates that the 
capacity of the public sector is insufficient [9]. 
 
The epidemiological transition and NCD’s 
As previously mentioned, Sri Lanka has an increasing prosperity making up the foundation 
for the epidemiological transition, shifting from infectious disorders to non-communicable 
diseases, NCD’s. The NCD’s are generally divided into four groups: cardiovascular diseases, 
chronic respiratory diseases, diabetes and cancer [10]. There are also other groups included, 
such as mental disorders. Risk factors are related to Western lifestyle and the consequences of 
it. Some examples are hypertension, obesity, use of alcohol, use of tobacco, dyslipidemia and 
physical inactivity. According to WHO these factors are expected to increase in Sri Lanka [8]. 
NCD’s are the leading cause of death in the world (63%) and the majority of these deaths are 
in low-middle income countries [10]. Also, in Sri Lanka, NCD’s are the leading cause of 
death, responsible for 75% of the total deaths each year. The part attributable to cancer has 
gone from fourth to second biggest group the past ten years [4]. The burden will continuously 
grow due to the ageing population [4] and the higher prevalence of risk factors. To manage 
the increasing demand of medical care, 900 healthy lifestyle centers, HLC’s, were introduced 
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all over the country in the year of 2011. The function of these centers are to screen for these 
diseases and spread information to the population about risk factors [11].  
 
The cancer transition 
A component of the epidemiological transition is the increasing incidence of malignancies. In 
a study published in Lancet Oncology 2012 it was predicted that the incidence of all cancers 
globally will increase from 12.7 in 2008 to 22.2 million by 2030. The same study declares the 
geographical differences between cancer types. Cancer of the colorectum, female breast, lung, 
and prostate stands for more than half of the total cancer burden in countries with very high 
and high HDI. Compared to those regions, the countries with medium HDI had a higher 
incidence of malignancies of the oesophagus, stomach and liver. The most frequent cancer 
types in countries with low HDI was cervix, female breast, Kaposi’s sarcoma and non-
Hodgkin lymphoma. The conclusion was that socioeconomic progress leads to reduction in 
cancers that are related to infections and an increase in cancers related to the Western 
lifestyle, the so called cancer transition [12].  
 
Colorectal cancer is globally the third biggest group of cancers and is the fourth most 
common reason for cancer-related death. The differences in incidence can be up to tenfold 
between different countries [13]. According to Arnold M. et al (2017) the increase of CRC 
will run up to more than 2.2 million new cases by 2030, a 60% increase. Similar to the study 
in Lancet Oncology 2012, they report a clear difference regarding geographical incidence 
depending on the level of Human Development Index [14]. Since Sri Lanka places above the 
average HDI, the country is more frequently exposed to cancer types associated with a higher 
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HDI than before, such as CRC.  
According to WHO GLOBOCAN in 2018, CRC represents 6.1% of the total number of new 
cancer cases in Sri Lanka and is the fourth most frequent cancer (excluding non-melanoma 
skin cancer) in the country [15]. The National Cancer Control Programme (NCCP) in Sri 
Lanka presented in 2014 that CRC had an age-standardized rate of 6.9 per 100,000 world 
population [16]. This is an upward trend. WHO estimated the crude rate in the year of 2000 to 
be 3.2 per 100,000 women and 4.9 per 100,000 men [17]. Other countries in South Asia, such 
as China, Japan and South Korea, also reported a higher incidence during the past few decade 
[18]. Sweden is no exception from this trend. Beside an ageing population, this can be 
addressed to a real increase which in Sweden mainly consists of colon cancer. CRC is the 
third most common cancer type in Sweden and 6500 people were diagnosed in the year of 
2017. The age standardized incidence of colon cancer per 100,000 population in 2017 was 
approximately 38 for women and 46 for men. The corresponding numbers for rectal cancer 
were 14 for women and 25 for men [19, 20], which is in line with the European average. 
 
Development and clinic of CRC 
Thus far, this report presents that an increasing HDI induces the epidemiological transition, 
which includes the cancer transition and a higher incidence of CRC. The etiology of CRC is 
multifactorial and not fully defined. It can be caused either by spontaneous or hereditary 
mutations. Spontaneous mutations stand for the greater part. Established risk factors are 
ageing, inflammatory bowel diseases, radiation towards the pelvic area and factors related to 
lifestyle. Red meat, physical inactivity, obesity, diabetes and use of alcohol and tobacco are 
some of them - the same as for all NCD’s. Hereditary forms stand for approximately 10-15% 
 10 
[21], were familiar adenomatous polyposis (FAP) and hereditary non-polyposis colorectal 
cancer syndrome (HNPCC) are the most well-known [22]. 
 
The predominate model to explain the development of most of the CRC, is malignant 
transformation of adenomas into adenocarcinomas. This is via multiple steps involving series 
of genetic alterations and mutations. The process can take 5-10 years [22]. The problem with 
CRC, as with many other cancers, is that symptoms often come in a late phase. In addition to 
that, symptoms often are ambiguous. Fecal blood, anemia and change in bowel habits are 
some examples [13]. An acute debut is less common. It occurs in 25% of the colon cancers 
and is considered rare for the rectal cancers. The initial diagnostic work up is by taking a 
history, digital rectal palpation, rigid sigmoidoscopy and laboratory tests for detection of 
anemia, as well as fecal occult blood. If suspicion of CRC, further investigation with 
colonoscopy and radiology is required [22].  
 
Classification and treatment 
Prognosis and composition of the treatment are dependent on the stage of the cancer and the 
general health of the patient, which can be defined by ASA classification and eventual 
comorbidities. In order to stage colon cancer, CE CT (contrast enhanced computer 
tomography) scan of the thorax, abdomen and pelvis is done. For rectal cancer, MRI of the 
pelvis replaces the CE CT pelvis as the most accurate method. At CSTH, CT chest and MRI 
pelvis are not considered mandatory [23]. 
 
Based on the imaging reports, the tumour is classified according to the UICC (International 
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Union Against Cancer) TNM classification. T describes how deep the tumour penetrates 
locally in the bowel wall, while N covers metastasis to regional lymph nodes. M indicates 
whether distant metastasis have been found or not [13]. The primary treatment is surgery. 
Both laparoscopic and open techniques can be used. In Sweden the majority is laparoscopic, 
while standard in Sri Lanka still is open. After surgery, a temporary or permanent ostomy 
often is needed. Different types of surgical procedures are made depending on the localization 
of the tumour [23]. In addition to surgery, oncologic treatment can be used in selected cases. 
The oncologic treatment can be neoadjuvant or adjuvant, e.g. preoperative or postoperative, 
and consist of radiotherapy, chemotherapy or the combination, chemoradiotherapy. 
Radiotherapy is given to rectal cancers that are locally advanced according to MRI pelvis and 
have high risk factors for recurrence. It has proven to decrease the risk of local recurrence and 
has the best effect given prior to surgery. Neoadjuvant chemoradiotherapy is given to more 
advanced rectal tumours. Adjuvant chemotherapy is preferably given to colon cancer with 
spread to regional lymph nodes being a high risk factor for recurrence. The purpose of 
adjuvant chemotherapy is to eradicate micro metastasis and has greater evidence for colon 
than rectal cancer. Colon cancer is not treated with radiotherapy [13].  
 
Follow up and screening 
There is weak evidence for the benefit of follow up programs. Therefor the composition and 
value of it is controversial and each country has their own national guidelines. The purpose of 
the follow up is to detect recurrence in time to be able to treat with curative intension. 
Recurrences are of different types: local, regional and distant. Local recurrence means at the 
site of the index cancer (including nearby tissue and lymph nodes), regional means close to 
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the primary site and distant considers spread to other organs (the same as distant metastasis or 
metastasis). The majority of the recurrences occur within 2-3 years after surgery and appear to 
be primarily located outside the lumen of the bowel. Liver is the most common location of 
distant metastasis, followed by lung and para aortic lymph nodes. Therefor follow up 
investigation should concentrate upon these areas [13, 22]. The tumour marker 
carcinoembryonic antigen (CEA) is one way of follow up. An increase in the serum level of 
CEA after treatment can be a sign of recurrence of the tumour. Though, recurrence can go 
without higher levels of CEA [22]. 
 
At CSTH the opinion is that comprehensive follow up is needed. All patients go through the 
same routine postoperatively, regardless of staging. This includes serum CEA 3 monthly and 
CE CT abdomen or pelvis 6 monthly during the first 2 years after surgery. The period 2 to 5 
years after the surgery CEA is done 6 monthly and CE CT yearly. Colonoscopy is done 
annually. The intention is to follow the patients for at least 5 years [B. Gamage, 2020-02-06]. 
In Sweden, the composition of the follow up is decided by an algorithm, depending on the 
stage of the cancer and the health condition of the patient. The question “would the patient 
benefit from early detection?” is central. For instance, CRC stage I that has been through 
radical surgery gets no follow up since the risk for recurrence is so low. Patients with more 
advanced tumours are selected for a systematic follow up program which has similar 
constitution to the one at CSTH (colonoscopy, CEA, CE CT liver and thorax and MR pelvis) 
[13].  
 
Both Sweden and Sri Lanka still remain without national screening programs, in spite of the 
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fact that WHO has qualified CRC for screening. Trials are pending in Sweden. None of the 
methods fecal occult blood test (FOBT) or endoscopic examinations (rigid or flexible 
sigmoidoscopy, colonoscopy) has yet shown to be both safe, easy and have a specificity and a 
sensitivity high enough [13]. Though, the incidence of CRC in Sri Lanka is still too low to 
benefit from screening. 
  
Survival measurements  
Estimation of survival can be done with different measures that are more or less relevant 
when it comes to cancer survival. Absolute survival (also called overall survival or just 
survival) is the percentage of patients alive after diagnosis or start of treatment [24]. Relative 
survival means the probability to survive in the absence of other causes of death besides 
cancer. It is defined as the ratio between observed survival and expected survival. This is 
done using population data based on gender, age and time period [25]. Another way of 
measuring survival rate is by looking at cause-specific survival. Cancer-specific survival 
excludes patients who died from other diseases than cancer. It is considered a more accurate 
estimation than overall survival. Overall survival risks presenting a lower survival than what 
is actually true for the specific cancer type [24]. 
 
The Sri Lankan CRC compared to the Swedish CRC 
Despite the fact that the Asian countries follow the path of the countries with higher Human 
Development Index (HDI) regarding increased incidence of CRC, several studies have 
suggested a difference in the Asian pattern of this malignancy compared to the Western 
pattern. The distinctions regard tumour location, age at diagnosis, tumour stage and survival. 
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Both the National Sri Lankan registers [26] and studies that have been conducted in Colombo, 
Sri Lanka [17, 18], presents rectum as the major tumour location. On the contrary to Swedish 
registers, reporting a preponderance of colon tumours [19, 20]. The studies have shown that 
Sri Lankan patients with CRC are of younger age [17, 18] in comparison to Swedish CRC 
patients [13].  Also, a poorer absolute 5-year survival in Sri Lanka than in Swedish reports 
could be seen [17, 19, 20]. 
 
The Sri Lankan Cancer Registry (SLCR) has been maintained by the National Cancer Control 
Program (NCCP) since 1985. There is no legal liability for the hospital or pathology 
laboratories to report data to it. Still, in 2014 the registry was said to cover more than 80% of 
the total number of cancers in the country. Though the data in SLCR does not include 
mortality. The current mortality rates are numbers that are collected in the district of Colombo 
[27]. Even though improvements have been made regarding data collection and reporting, this 
register is still incomplete, and data are of insufficient quality. Altogether, there is a clear 
research gap since the pattern and long term outcome of the Sri Lankan CRC have not been 
fully surveyed. 
 
The hypothesis of this study was that because of the considerably higher incidence of CRC in 
Sweden compared to Sri Lanka and the general diversities of the countries, there may be 
differences in long term outcomes and pattern of the disease.  
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Aim  
The main aim of this thesis was to compare the long term outcomes after Colorectal cancer 
surgery at Colombo South Teaching Hospital in Sri Lanka, with corresponding Swedish data. 
The secondary aim was to determine the patterns of the Sri Lankan colorectal cancer and to 
outline potential differences from the Swedish version of the disease. 
 
Specific research questions 
What are the long term outcomes 5 years after Colorectal cancer surgery regarding absolute 
survival and recurrence rate? 
What are the patterns of the Sri Lankan Colorectal cancer regarding TNM classification, 
tumour location, ASA class, gender and age? 
Is there any association between 5-year absolute survival and TNM classification, ASA class, 
tumour location, gender and age? 
Can differences between the Swedish and the Sri Lankan Colorectal cancer be detected? 
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Material and Methods  
Study design  
The thesis was a descriptive and retrospective medical record study. It took place between the 
5th of February until the 16th of Mars 2020 at the Professorial Surgical Unit at Colombo South 
Teaching Hospital (CSTH), Sri Lanka.  
 
Data collection   
Information was collected from three different sources. The data register was the main source. 
It covered patients that had been diagnosed with Colorectal cancer (CRC) by Doctor 
Bawantha Gamage. Access to this was granted by him. The register was not complete. To 
enlarge the sample size and complement data, the medical records were used. These were 
compiled in cooperation with Stina Lindholm. The Sri Lankan patients do not have 
identification numbers. After discharge from a hospital stay, the medical record of the patient 
was filed under a temporary BHT, bed head ticket number. One person can therefore have 
many BHT’s, making it hard to keep track of the medical history. In the operation theater at 
the hospital, a book of all the BHT’s of patients that had undergone surgery at CSTH were 
stored. A list of the BHT’s of the CRC cases was made. This contained the BHT of the 
patient, the name of the patient, type of surgery and date of surgery. With help from the staff 
at the medical record department, the correct medical record for those specific surgeries was 
obtained; all in paper form. Also, MDT sheets in paper form were added continuously from 
the recent clinic meetings during the time of the study. Those were patients either newly 
diagnosed with CRC or with recurrence of CRC. The variables were collected according to 
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the Data Collection Form (see Appendix A). All patients did not have contact information. 
The ones that had available telephone numbers were contacted to obtain more information 
regarding the long term outcome. To conduct the telephone calls, a list of questions was made 
(see Appendix B). The calls were carried out by medical students or practicing doctors at 
CSTH between the 17th of February to the 12th of Mars 
 
Study population 
All patients with the diagnosis of CRC were eligible for inclusion. Cases with missing 
information about one variable were excluded from that specific analyze. The study group for 
the long term outcome analysis was limited to the patients that had undergone surgery of the 
colon or the rectum, regardless of the type of procedure. Both acute and elective operations 
were included, as well as laparoscopic and open methods. The 104 patients that had available 
telephone numbers were called. 26 did not answer and 1 patient did not want to participate. 77 
were reached, resulting in the answering frequency 74%. Out of these, 7 patients had not had 
any surgery yet and 3 had died before surgery was done. These 10 were excluded from the 
follow up. A total of 185 patients were included in the study, all diagnosed with CRC. 180 
were taken from the register and the medical records while 5 were taken from the MDT sheets 
of the recent clinic meetings. 37 patients from the register were excluded from the beginning 
due to missing diagnosis or other diagnosis than CRC. When adding the data from the 
telephone follow up, in total 77 patients had data of long term outcome, whereof 68 had 5-
year follow up. The surgery dates stretched from February 2010 to January 2020. A flow 
chart of the data collection is presented in Figure 1.
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Figure 1. Flow chart of data collection. n= number of patients.  
 
Age, gender and ASA class 
179 patients had data about age and 184 about gender. The age of the Sri Lankan patients was 
defined as age at surgery in whole years. For cases when there was no information about date 
of surgery, the age was set as age at diagnosis. This was based on the assumption that the age 
of the patient was reported the year when it was put in the register. Data about ASA class, the 
American Society of Anesthesiologists physical status classification, was obtained for 114 
patients. 
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Tumour location  
185 patients had reported data about tumour location. When dividing into colon and rectal 
tumours, lesions located aborally to the level 15 cm from the anal verge were set at rectal and 
the rest as colon. The ones in the rectosigmoid junction, RSJ, were classified as rectal if a 
rectal surgery (anterior resection, abdominoperineal resection) was done and as colon if a 
colon surgery (sigmoid colectomy) was done. RSJ tumours were classified as a colon cancer 
in cases when no surgery had been done or information about it was missing.   
 
TNM staging  
The TNM stage was specified from histopathological reports (n=32), radiological reports (CE 
CT abdomen thorax and MRI pelvis, n= 40) or combinations of them (n=22). 
Subclassifications were not included. Histopathological reports were considered to be most 
accurate regarding the T- and N-stage, wherefor it was the primary source. The second most 
accurate was considered to be MRI. If the report had a description of the tumour but no TNM 
classification, then the TNM staging could be estimated for some cases (n=32) based on the 
radiological and/or histological report. 12 patients were lacking TNM staging. All together 
138 patients were staged according to the TNM classification. 
 
Long term outcome 
Follow up time was calculated in months from the date of surgery until either the date of the 
latest investigation, the date of the telephone call or the date of death. If the patient underwent 
an investigation (radiological, endoscopic, blood sample) he or she was assumed to be alive at 
that date. Time until recurrence was calculated from the date of the surgery until the date of 
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the earliest imaging or endoscopic examination that discovered the recurrence or the date of 
the first treatment of the recurrence. If no information about recurrence was found in the 
report from the investigation, it was registered as no recurrence. The dates were specified in 
years and months. 5-year follow up included patients that were followed from between 1 to 63 
months. 
 
Swedish data collection and study population 
Swedish data of all the CRC cases about age groups, gender and tumour location was 
collected from registers of the Health and Human Services Department of all new cases in 
2018, in total 6809 patients. Age was specified as age at diagnosis. Raw data from the 
Colorectal Cancer Register, Regional Cancer Centre North, was applied for and used to 
estimate absolute survival and mean age at diagnosis. It contained all the 23,772 patients that 
had gone through resections in Sweden from 2015 to 2019 and included data about gender, 
age at diagnosis, colon or rectal cancer, date of resection, date of death or date of censorship. 
The resections included were AR (anterior resection), Hartmann’s procedure, right sided 
hemicolectomy, ileoceacal resection, colectomy, sigmoid resection, transverse colon 
resection, left sided hemicolectomy and APR (abdominal perineal resection).   
 
Statistical methods 
Data was collected and stored in an excel file. The statistical analyzes were done with IBM 
SPSS statistics version 26. Frequencies and cross tables were used for the descriptive 
statistics. The Kaplan-Meier method was used to calculate survival rates and binomial 
distribution to calculate risk for death and recurrence. Univariate survival analyses for death 
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were performed using the logistic regression. P-value <0.05 was considered significant. Age 
was analyzed both as a continuous variable and by age-groups in the descriptive statistics, and 
as a continuous variable for the logistic regression. 
 
Ethical considerations 
Ethical clearance was received from Colombo South Teaching Hospital (see Appendix C) and 
from the Ethical Review Committee at CSTH, University of Sri Jayewardenepura (see 
Appendix D). The study aligns to the principles of the WMA Helsinki declaration for medical 
research and obeys the human rights. Data was treated anonymously using given ID numbers 
instead of names and coding key in a separate document.  
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Results 
Gender, age and ASA class 
The mean age of the Sri Lankans was 62 years with a range from 15 to 89. In the Swedish 
context mean age was 71.2 years. The age group with most patients in Sri Lanka were 60-69 
years (34%) and 50-59 years (20%). Swedish patients were older, with the biggest age groups 
70-79 years (38%) and 80 years and above (27%). The age groups are presented in Figure 2. 
There were 105 (57%) men and 79 (43%) women in the study group. Similar distribution of 
gender was seen in the Swedish patients (52.5% versus 47.5%). 68 Sri Lankan patients were 
ASA class 1, 43 class 2 and 3 class 3.  
 
Figure 2. Comparison of age groups between Sri Lanka and Sweden. X-axis presents age groups in years and y-
axis presents percentage of patients in each country. 
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Tumour location  
In Sri Lankan patients rectum was the most common site with 60% (111) compared to colon 
40% (74). 3 of the patients with rectal cancer had involvement of the anal canal. In the 
Swedish population colon represented 70.7% (4,815) and rectum 29.3% (1,994). See Figure 3. 
 
Figure 3. Tumour location in Sri Lanka compared to Sweden. Rectal tumours are 60% of the Sri Lankan and 
29.3% of the Swedish patients, while corresponding numbers for colon tumours are 40% and 70.7%.  
 
TNM staging  
12% of the patients had distant metastasis, M1, when discovered and the majority of the 
tumours had grown through muscularis propria (T3) or had trans serosal spread (T4), 32% 
and 30%, respectively. See Figure 4. 
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Table 4. Frequencies and percentages of stages in the TNM classification of the Sri Lankan patients with data 
about TNM staging. X means unclassified. Count = number of patients. Column N % = percentages  of patients. 
 
Overall survival  
9 of the 68 patients that were followed for 5 years (1 to 63 months) died. After 5 years (69 to 
120 months) there were 9 patients followed up, all alive. The mean follow up time was 27 
months (range 1 to 120 months). Out of the 8 deaths, 2 were cancer related, 4 were due to 
other cause and 2 with unknown cause. The risk for death was estimated with binomial 
distribution. 0-5 years after resection the risk in Sri Lanka was 13.2% [95% CI 5.8-21.9] 
compared to 18.4% [95% CI 18 to 19] in Sweden. The difference in proportion of deaths was 
not significant, 6.6% [95% CI -4 to 13]. Absolute 5-year survival was 86.8% in Sri Lanka and 
81.6% in Sweden. 
 
Kaplan-Meier survival analysis failed to show significant differences in survival 0-5 years 
after surgery between the Sri Lankan and the Swedish study groups (see Figure 5). The 
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difference was estimated to 15 days with overlapping confidence intervals. The mean survival 
time for Sri Lanka was 52.5 months [95% CI 45.6-59.5] and for Sweden 52.0 [95% CI 51.8-
52.3].  Neither with overall comparisons with Log Rank, Breslow nor with Tarone-Ware any 
significant difference could be found.  
 
Figure 5. Kaplan-Meier plot for 5-year overall survival among Colorectal cancer patients in Sri Lanka versus 
Sweden. Time is reported as time after surgery, specified in months (1 to 63 months). Cum survival = cumulative 
survival. 
 
In attempt to estimate correlation between death and time until death and the variables, 
logistic regression was used, analyzing each variable individually. The results are shown in 
Table 1. Age, solemnly, had significant correlation with death. No correlation with gender, 
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ASA class, TNM classification (T and M-classification) or tumour location was seen. 
 
Table 1. Variables of Colorectal cancer patients potentially affecting risk for death within 5 years after surgery. 
Logistic regression was used for analysing odds ratio for each variable individually. OR = odds ratio. CI = 
confidence interval. n = number of patients.  
 
Out of the 68 patients that were followed for 5 years (1 to 63 months), 13 encountered a 
recurrence. No recurrences happened after 5 years (69 to 120 months). The recurrences were 
allocated to liver metastasis (5 patients), liver and lung metastasis (3 patients), local 
recurrence (1 patient) and unknown type of recurrence (4 patients). 0-5 years after surgery the 
risk for recurrence was 24% [95% CI 14-35], estimated with binomial distribution. 2 deaths 
were due to distant metastasis and therefor included in the group of recurrences. Remaining 
deaths were excluded from the calculation. The mean time until recurrence was 91 months 
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[95% CI 76-105].  
 
Comparisons of patients below and above 50 years  
33 of the total 179 Sri Lankan patients, 18.4%, were younger than 50 years old. That is more 
than a 3 times higher proportion than in Sweden (5.4%). See Figure 6.  
 
Figure 6. Percentage of patients below and above 50 years in Sweden compared to Sri Lanka. 
 
 The two age groups had comparable distributions of gender. The younger group had a higher 
proportion of rectal tumours (66.7%) and lower proportion of colon tumours (33.3%), 
compared to the older group (59.6% and 40.4%). The difference in tumour location between 
the age groups did not occur in the Swedish population. Rectal tumours stood for 29.2% 
(1,882) in the older group and 30.4% (112) in the younger group. Corresponding numbers for 
colon tumours were 70.8% (4,559) and 69.6% (256). 
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112 of the older and 24 of the younger patients had data about TNM classifications, see 
Figure 7. More than half of the young patients had tumour staged T4 (54%) compared to 
hardly one fourth of the older (24%). Regarding distant metastasis the two age groups had a 
hardly noticeable differences (older 12% versus younger 13%). The frequency of deaths 
within 5 years after surgery was 0% in the younger groups and 6.2% (9 of 146) in the older 
group. Recurrence had the same pattern, 0% among the patients below 50 years and 8.9% (13 
of 146) among the patients above 50 years old. 
 
 
Figure 7. TNM classification for patients below and above 50 years old. X means unclassified. 
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Discussion 
Key findings 
This thesis set out with the aim to investigate patterns and long term outcomes of the Sri 
Lankan Colorectal cancer (CRC) and determine whether differences from the Swedish CRC 
could be detected. It was found that the CRC population in Sri Lanka was younger than in 
Sweden. Mean age differed with almost 10 years (62 versus 71) and the percentage of patients 
younger than 50 years old was more than 3 times higher (18.4% versus 5.4%). The majority 
of the patients were 60-69 (34%) and 50-59 (20%) years old, a substantial difference from 
Sweden where 70-79 (38%) and 80+ years (27%) were the biggest age groups. These findings 
are in line with results from other theses. Two studies in Colombo showed that almost one 
third of the patients were younger than 50 years old (26-28%) when diagnosed [17, 18]. The 
median age at presentation was 60 (range 9 to 88) [17] and the highest proportion was in the 
age between 50 and 80 [18]. The Ceylon Medical Journal presented in the year of 2000 that 
19.7% of the Sri Lankan patients with CRC were 40 years or less [28]. In Sweden the 
percentage of colon and rectal cancer patients below 50 years old stand for 4% respectively 
5% of the total amount of CRC patients [13]. The median age at diagnosis was 74 years [22]. 
A possible explanation to the considerably big group of young patients in the Sri Lankan CRC 
patients can be a generally younger population. The socioeconomic improvement in Sri Lanka 
brought an increase in the life expectancy which is closing in to the level of Sweden, 75.5 
(2018) [1] compared to 82.2 years (2016) [29]. Still, the proportion of the population in each 
age group differs between the two countries. The population pyramid in Sweden shows 
greater number of people in the older ages compared to in Sri Lanka. Only 5.1% of the Sri 
Lankan population is 70-79 years old, while the corresponding Swedish number is 9.6% [30, 
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31]. This is likely to have an influence in the age comparison of the CRC patients between the 
two countries.  
 
Furthermore, another key finding was the tumour location. The distribution of CRC’s in Sri 
Lanka was almost opposite to that in Sweden; 60% rectal and 40% colon tumours in Sri 
Lanka, versus 29% rectal and 71% colon tumours in Sweden. The preponderance of rectal or 
left sided tumours in Asia compared to the West is in line with previous studies. Both Zhang 
S. et al (2009) and Fang YJ. et al (2013) present rectum as the major tumour site in China [32, 
33]. Higher rates of rectal cancer was also found in China, including Shanghai and Hong 
Kong, when comparing with the US [34]. According to Sri Lanka’s Cancer incidence data in 
the year of 2011 rectum is the most common site for CRC, followed by sigmoid colon [26]. A 
study in the Colombo region in Sri Lanka by Chandrasinghe et al. (2017) found left sided 
CRC in 82% and rectosigmoid in 77% of the cases [18]. These results were supported by 
another study of CRC patients in the same region [17]. This in contrast to what Swedish CRC 
registers formerly reported. Swedish patients show preponderance of right sided colon and 
with a proportion colon versus rectal cancer in approximately 70% and 30%, respectively [19, 
20]. These numbers are in line with the other Western countries. 
 
Arnold M. et al (2016) suggest that CRC in Asian countries have poorer survival than the 
Western countries [14]. Medium HDI (Human Development Index) countries, such as the 
Philippines, show increase in both incidence and mortality of CRC. Western countries, that 
generally have high HDI’s, present declining incidence, as well as mortality of CRC. The 
correlation between tumour staging and survival is well established. A possible explanation 
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for poorer survival could be later discovery of the disease, thus a more advanced stage of the 
tumour. Reasons for later diagnosis might be the constellation of the health care system and 
the shortage of knowledge in the population. In this thesis survival after surgery was 
investigated. The absolute 5-year survival in the Sri Lankan group was higher than in the 
Swedish one, 88% versus 82%. Mean 5-year survival differed with 15 days. The difference 
was not statistically significant. Perera et al (2008) presented an absolute 5-year survival in 
Sri Lanka of 52% [17]. Corresponding numbers for Sweden, estimated by the Regional 
Cancer Centre North, were 57-60% [19, 20]. The survival rate of the Sri Lankan patients in 
this thesis is considerably higher. If these numbers are true, one explanation might be that the 
health care has improved the standard and that information spread about NCD’s has 
succeeded. An important factor for discovering CRC is that the doctor is aware about the 
disease. Along with the rise in incidence that awareness might have been strengthened. 
Another explanation could be sampling bias. Only the patients that were healthy enough to 
undergo surgery were included in the long term outcome analysis. It creates a study group 
with risk of having survival rates that does not reflect the whole group of CRC patients. In 
addition, there is a risk that deceased patients become drop-outs, increasing the survival rates 
even more. Furthermore, important factors affecting the survival rates are the high expertise 
of the surgeons at the teaching hospital in combination with young patients operated.  
The small sample size and the substantial amount of missing data have an impact as well. It is 
probable that Sri Lanka would have a lower survival due to the constitution of the health care 
system and more delays in the discovery of the disease than in Sweden. Taking these factors 
in consideration, a poorer survival in the Sri Lankan patients cannot be rejected. As 
mentioned in the previous section, the structure of the population pyramids in the two 
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countries differs [30, 31], which is also probable to affect the comparison of the survival. Age 
is not only a risk factor for CRC, but also for death. The effect on the survival rates could be, 
at least partly, evaded by performing age stratification on the data. Besides failing to show 
difference in survival, this study also failed to present more advanced M-stage in the Sri 
Lankan patients, of which only 12% of the patients had distant metastasis. A lesser part set 
against the Swedish numbers of 20-25% [22].  
 
Risk for recurrence 5 years after surgery was estimated to 24% (range 14-35) for CRC. The 
numbers for recurrence presented in the Swedish registers are in the range 5-13% [19-21]. 
Swedish registers reported separately depending on staging, time after surgery, type of 
recurrence and tumour location which makes comparison hard to interpret. It is therefore of 
limited value. Since there were only 13 recurrences in the Sri Lankan group, type of 
recurrence was not analyzed. Due to the small sample size of the Sri Lankan group the risk 
might have been overestimated. Also, the Swedish data behind these numbers is known to be 
subject for under-reporting. Thus, the low frequency of recurrence in Sweden and the high 
frequency in Sri Lanka might not be representable. Another indication of the small sample 
size is the non-significant results in the correlation tests. The only true correlation found to 
increase risk for death was age. No correlation was found for neither ASA class or TNM 
stage, variables that otherwise are mostly probable to affect the risk for death. Once again, 
this puts light on the substantial shortage of data in Sri Lanka and the need for further 
research in this area. 
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The patients younger than 50 years had more locally advanced tumours, stage T4, than the 
older ones (54% versus 24 %). No difference in frequency of distant metastasis at diagnosis 
was found. As previously discussed, the staging is a high predictor of the prognosis. 
Implicating that the advanced stage in younger patients would provide poorer prognosis. 
Thus, this does not reflects in the long term outcome analysis. Nothing in the results speaks 
for a higher risk for death or recurrence for patients younger than 50 years old. None of the 
young patients had any recurrence or died. Though, it is impossible to say whether the lack of 
difference is due to small sample size or if it actually reflects the reality. 
 
So far, results from this and several other studies suggest that different patterns of the CRC 
exist and many possible explanations are discussed. Besides age, environmental factors and 
lifestyle are known to affect the risk for sporadic forms of CRC. Deen et al. (2016) declared 
that countries with high incidence of young CRC cases are not the ones with high red meat 
consumption [35], opening up for other theories. Diverse ethnicities not only come with their 
specific lifestyles, but also with genetical variations which some studies point out to play a 
role in the diverse character of the malignant disease [34, 36]. Migrated South Asians in Great 
Britain had more rectal cancers, were of younger age and had more advanced stage at 
presentation compared to the Caucasians [36]. Japanese patients both in Japan and those 
migrated to the US had higher rates of rectal cancer than other ethnic groups in the US [34]. 
These circumstances are all suggestions of the importance of the genetics in the presentation 
of CRC in different ethnicities. Though, since ethnicity is a combination of lifestyle and 
genetical compositions it becomes hard to define what would play the key role in this context. 
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Study Limitations 
The biggest limitation of the study is the low number of patients and lack of data. The way of 
reporting data, conducting registers and follow ups is not well established in Sri Lanka. One 
reason to this is the setup of the medical records in paper form and the usage of BHT’s instead 
of identification numbers. Also, that contact information is missing in many cases or that 
patients do not own telephones makes long term outcome hard to survey. 
 
While the Sri Lankan material had lot of shortages, the Swedish study group was of good size 
and had good coverage, resulting in precise estimations. This cannot be rejected to affect the 
estimation of the differences between the two countries. The age of the Swedish CRC patients 
was taken from the data of new cases in 2018. In contrary to the Sri Lankan patients that are 
collected from different years. Though, the distribution of ages most likely do not differ 
between years so it would not affect the results. The Swedish data about age was specified as 
age at diagnosis. Data about age in Sri Lankan differed in report occasion. It could be either at 
surgery or at diagnosis. However, reporting date is not the only parameter affecting. It is 
probable that there is less delay in diagnosing in Sweden than in Sri Lanka. When interpreting 
the age comparisons these factors need to be kept in mind.  
 
The age groups and the distribution of gender were consistent with data from the National 
Cancer Control Program (NCCP) in Sri Lanka, making it credible that the study group is 
representable for the Sri Lankan population. Though this deviates regarding the tumour 
location. NCCP presents a close to even distribution between colon and rectum [16]. It brings 
up the question about how well the NCCP have surveyed the CRC patients in Sri Lanka and 
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also how well the majority of rectal cancers in this thesis reflects the actual truth. 
 
Another limitation is that the absolute survival has been calculated, not the relative. Relative 
survival estimations require life tables and sufficient amount of data for accuracy. In addition, 
the calculations are advanced. Therefor it could not be carried out. Neither could cancer-
specific survival calculations be done. This was due to inadequate quantity of deaths and 
information about cause of death. Absolute survival or overall survival is less representative 
for the survival of CRC alone. It is also harder to interpret and compare with other countries 
since relative survival is the measure predominantly used. The same goes for recurrence. Type 
of recurrences could not be analyzed due to the small study group. Tumour stage was not 
compared since there were no available data in the public Swedish registers about TNM class 
and due to shortage of time. 
 
The retrospective study design provided more patients than a prospective would have. Though 
there is a risk of missing out on people who have died. A prospective design would not have 
been possible to conduct under these circumstances, because of the short observation time and 
the aim to follow up for 5 years. Due to the system of the medical records and bed head 
tickets (BHT’s), the only way of follow up patients is by contacting them. One option would 
be to meet the patient at the clinic. Though that would be too time-consuming. Telephone 
follow up was the remaining workable alternative. The credibility of telephone follow ups in 
low-income countries can be discussed. Reporting of recurrence, age and dates might be 
doubtable. Patients are often uninformed and have shortage of knowledge. The fact that no 
other alternatives were available for follow up and the answering frequency of 74%, makes it 
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acceptable. Furthermore, only the patients that answered the telephone calls and had available 
telephone numbers were reached. Patients with lower standard of living who cannot afford a 
telephone are not represented in the results. Also, deceased and patients sick due to recurrence 
might be undiscovered. The survival results in this thesis therefor risk being higher than the 
actual number.  
 
Future studies with similar settings should have longer observational time and a bigger study 
group, especially for the long term follow up. More patients would make it possible to study 
different types of recurrences and different causes of deaths. Divisions into subgroups should 
be done. For instance, analyzing rectal and colon cancer separately. Estimation of the relative 
survival and for shorter time periods, both 0-3 years and 3-5 years after surgery, would be 
interesting to do. It would also be desirable to have equivalent data about all variables when 
comparing the two countries.  
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Conclusion and Implications  
This study provides support for the theory of a diversity in the pattern of the disease 
comparing Sri Lanka and Sweden, though only regarding tumour location and age. The 
conclusions that can be made are that the Sri Lankan patients are younger and have 
preponderance of rectal tumours. Though, these findings are limited by a small study group, 
data from only one hospital and highly competent surgeons performing the surgeries studied. 
The results are not fully conclusive when it comes to the complete character of the disease, 
especially for survival and tumour stage. This implies the need for more studies. If true 
diversities in the pattern of the disease can be detected, it may be favourable with different 
constitution of national guidelines regarding information programs, investigation, treatment 
and follow up. One suggestion is to increase the awareness of Colorectal cancer (CRC) in the 
general population Also, to make sure that doctors are aware of that CRC is not uncommon 
among young patients. Left sided and distal tumours (in rectum, rectosigmoid junction and 
sigmoid colon) are more easily detected than the right sided, opening up for usage of flexible 
sigmoidoscopy as investigation or screening method. From the results of this study, it would 
be probable that at least 60% of the tumours would be found with this technique. Earlier 
detection leads to less advanced stage and hopefully better prognosis. 
 
The differences in the character, above all the incidence of CRC, age of the patients and 
tumour location between Asian and Western countries of the CRC awaken new questions. 
Further research should be carried out to investigate the cause of the differences in the 
patterns and the incidence of the disease. Is it due to biological diversities of different 
ethnicities or varying environmental factors, such as red meat consumption or obesity? 
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Populärvetenskaplig sammanfattning  
Kolorektalcancer på ett Lankesiskt universitetssjukhus 
- En beskrivande och jämförande studie 
Tjock- och ändtarmscancer är den tredje vanligaste cancertypen i världen. Graden av 
insjuknande fortsätter att öka. Livsstilsrelaterade faktorer som rött kött, fysisk inaktivitet, 
övervikt, diabetes samt användning av tobak och alkohol är väl belagda riskfaktorer. Det har 
tidigare varit en sjukdom som företrädelsevis drabbar de västerländska länderna. Ekonomisk 
utveckling och höjd levnadsstandarden i låg- och medelinkomstländer medför ett 
västerländskt levnadssätt, som ökat förekomsten av de ovan nämnda riskfaktorerna. Sri Lanka 
har genomgått en betydande samhällsutveckling de senaste decennierna, vilket åtföljts av en 
ökad förekomst av tjock- och ändtarmscancer.  
 
Tidigare studier på tjock- och ändtarmscancer i Sydasien, däribland specifikt i Sri Lanka, har 
visat tecken på att den sydasiatiska tjock- och ändtarmscancern skiljer sig från den 
västerländska i sitt sjukdomsmönster. Det rör sig om en större andel yngre patienter, mer 
avancerade stadie på tumören, sämre överlevnad och majoritet av tumörer lokaliserade i 
ändtarmen istället för tjocktarmen, vilket är det som dominerar i väst. Ännu har register, data 
och studier varit otillräckliga för att till fullo fastställa detta. Kartläggning av sjukdomens 
karaktär skulle kunna få betydelse för utformning av informationsprogram, utredning, 
behandling och uppföljning, som förhoppningsvis resulterar in en förbättrad överlevnad. 
 
 Syftet med denna studie var att undersöka 5-årsresultat och sjukdomsmönstret av den 
lankesiska tjock- och ändtarmscancern samt att fastställa om det fanns skillnader gentemot 
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den svenska tjock- och ändtarmscancern. Data samlades in under knappt två månader på ett 
universitetssjukhus i södra Colombo. Journaler, register och telefonuppföljning resulterade i 
ett studiematerial omfattande 185 patienter, varav 68 hade uppgifter om 5-årsutfall. Svenska 
data erhölls från Nationella cancerregister för tjock- och ändtarmscancer. 
 
Det man fann var att 18% av patienterna i Colombo var yngre än 50 år, mer än 3 gånger så 
stor andel som i Sverige. Medelåldern i de olika länderna skiljde sig med nästan 10 år, 62 år i 
Sri Lanka jämfört med 71 år i Sverige. Majoriteten av de lankesiska patienterna var mellan 
59-69 år, medan merparten av de svenska var över 70 år gamla. 60% av de lankesiska 
tumörerna fanns i ändtarmen och 40% i tjocktarmen. Ett nära motsatsförhållande till Sverige, 
där fördelningen är 29% ändtarm och 71% tjocktarm. Av de 68 lankesiska patienter som 
följdes i 5 år skedde 8 dödsfall. 13 fick återfall av sjukdomen. Den absoluta 5-
årsöverlevnaden var 88% och medelöverlevnaden 52,5 månader. Någon signifikant skillnad i 
5-årsöverlevnad jämfört med den svenska gruppen kunde inte påvisas. Risken för återfall 
inom 5 år var 24% hos de lankesiska patienterna. Resultaten stödjer de teorier om att 
cancersjukdomens karaktär skiljer sig mellan de två länderna med avseende på ålder och 
tumörlokalisation. Studien kunde inte påvisa skillnader gällande överlevnad. Det är troligt att 
detta har sin grund i det knappa antalet patienter i studiegruppen samt att mycket data 
saknades i de register som fanns tillgängliga för denna studie, men kanske framförallt att 
studien var förlagd till ett universitetssjukhus med hög kompetens hos de verksamma 
kirurgerna. 
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Appendices 
Appendix A: Data collection form 
Date is reported in year and month. 
Name 
Telephone number 
Age or date of birth 
Gender 
ASA classification 
Anatomical distribution of the tumour 
TNM stage 
Histopathological and/or radiological report 
Date of surgery  
Type of surgery 
Follow up after surgery  
- Date and result of examinations (endoscopic examinations, imaging, blood samples) 
- Date and type of recurrence 
- Date and cause of death (cancer related or other cause) 
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Appendix B: Telephone follow up 
 
Hello, I am XX from Colombo South Teaching Hospital. 
Please can I confirm, is this …………………..? 
 
Questions: 
1. Date of birth (year and month)? 
2. Date of surgery (year and month)? 
3. Alive or not alive? 
3a. If alive: 
Recurrence or no recurrence of cancer? 
Date (year and month) and type of recurrence? 
3b. If not alive: 
Date of death? 
Cause of death? 
 
Thankyou very much for your time! 
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